Cheap online drugs store. Only branded medicine. All drugs FDA approved.
The most popular, comprehensive and up-to-date medicine online.



ED Treatment
1. Viagra - $ 1.26 per pill
2. Cialis - $ 1.73 per pill
3. Levitra - $ 2.08 per pill

Recently Added

Recent News
03/17/10 Nova Century Scientific to market and sell Diamedix’ products in Canada
IVAX Diagnostics, Inc. (AMEX:IVD), a fully integrated global invitro diagnostics company, announced that its subsidiary, Diamedix Corporation, has signed a distribution agreement with Nova Century Scientific (“Nova”), a leading Canadian distributor and manufacturer of diagnostic kits and laboratory supplies. Through this agreement, which marks IVAX Diagnostics’ entry into the Canadian market, Nova will market and sell 50 of Diamedix’s products, including analyzer instrumentation, under the Diamedix brand. Nova distributes products to hospitals, clinical laboratories and research institutions across Canada, and is a subsidiary of IMMCO Diagnostics, Inc. 03/17/10 Access MediQuip enhances Recall Management Service for implantable devices
Access MediQuip, LLC, the nation's first and largest provider of outsourced implantable medical device management solutions to the healthcare industry, announced today it has enhanced its proprietary Recall Management Service, "RMS," for its customers nationwide. The new release is designed to protect patients, inform and empower surgeons and facilities, and help payers improve quality while managing cost. 03/17/10 AstraZeneca's CRESTOR: Health Canada approves new indication
Approval based on JUPITER trial which demonstrated reduction of cardiovascular events by nearly half
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Top Category's Bestsellers

B [top]
Benzyl benzoat Buy Benzyl benzoat
C [top]
Calciu Lactic Buy Calciu Lactic
Celestoderm-V Buy Celestoderm-V
D [top]
Dermovate Buy Dermovate
F [top]
Freederm Tar Buy Freederm Tar
Freederm Zinc Buy Freederm Zinc
S [top]
Skin-Cap Buy Skin-Cap


Psoriasis Treatment

Psoriasis is a wide-spread skin disease distinguished by swelling and redness of the knees, soles of the feet, palms, scalp, lower back, and other locations. Inflamed area of the skin is usually covered with silvery scales that are itchy and feel sore. Other symptoms of psoriasis may vary depending on specific psoriasis type a person experience. People who experience pustular psoriasis usually develop blisters on the skin that are often thick with noninfectious pus. While inverse psoriasis is characterized by developing smooth and red patches that occur under the breast, near the genitals or in the armpits. Guttae psoriasis results in small, drop-shaped lesions of the lower extremities, scalp and trunk.

What actually causes psoriasis is still not known. It is considered that immune blood cells called T-cells, which normally protect human organism from foreign substances and infection, receive irregular signal and are put into action by mistake. This results in fast turnover and swelling of skin cells. In some cases hereditary factor, stress, infection and changes in weather may lead to any types of psoriasis.

Before beginning psoriasis treatment your health care provider should precise what type of psoriasis you experience as well as the severity of the disease and size of the involved areas. Usually psoriasis treatment include "1-2-3" approach.

  • Step 1 - Topical medications that are applied to the affected area.
  • Step 2 - Phototherapy (light treatment).
  • Step 3 - Treating the whole immune system with psoriasis medications(systematic therapy)

Category News

05/07/07 - RELIEVA Psoriasis Treatment Captures Attention Of The American Journal Of Therapeutics - Clinical Results Support Impressive Conclusions

Psoriasis is a common immune-meditated chronic skin disease often characterized as red, scaly plaques that itch, burn, sting, and bleed easily. Psoriasis afflicts approximately 125 million people worldwide; more than 90% of patients have the mild to mode

02/07/07 - People With Chronic Moderate To Severe Plaque Psoriasis May Be Undertreated

The National Psoriasis Foundation and Amgen (NASDAQ: AMGN), has announced survey findings which show that nearly 40 percent of 1,142 patients surveyed with chronic moderate or severe psoriasis are not currently receiving any treatment. These results were


Home Page|Info|F.A.Q.|Customer Support|About Us
Drugs XML FeedDrugs RSS Feed Subscribe Via My MSN Add to Google
We do not claim to be affiliated with the manufactures of drugs which are presented on our web site. We simply sell branded drugs and are not associating with the manufacturers. 2006 © Copyright. All Rights Reserved.